The Arrival of Eli Lilly’s Next Major Hit
The pharmaceutical industry has seen a significant rise in the popularity of glucagon-like peptide-1 (GLP-1) agonists in recent years. Names like Ozempic, Wegovy, and Mounjaro are all familiar in the realm of diabetes and obesity … Read more